Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Learn more about whether Bausch + Lomb Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Inari Medical (TASE:PMCN) Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the $4.68 billion medical device company.
Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...
KNOWN for its innovative take on the classic Japanese sukiyaki experience, Inari Sukiyaki has officially opened its second store at the 4th level of SM Aura Premier, 26th Street corner McKinley ...
Forbes does not accept payment for placement on lists.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback